Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye

Figure 3

A 74-year-old male with bilateral neovascular AMD ((a) and (b)). Six weeks following intravitreal injection of ranibizumab OS, there was a reduction in intraretinal and subretinal fluid OU ((c) and (d)).

(a)

(b)

(c)

(d)